Meniscus repair and regeneration : review on current methods and research potential by C. Scotti et al.
150 www.ecmjournal.org
C Scotti et al.                                                                                                               Meniscus repair and regenerationEuropean Cells and Materials Vol. 26  2013 (pages 150-170)                                                                    ISSN 1473-2262
Abstract
Meniscus regeneration is an unsolved clinical challenge. 
Despite the wide acceptance of the degenerative 
consequences of meniscectomy, no surgical procedure 
has succeeded to date in regenerating a functional and 
long-lasting meniscal fibrocartilage. Research proposed 
a number of experimental approaches encompassing 
all the typical strategies of regenerative medicine: cell-
free scaffolds, gene therapy, intra-articular delivery of 
progenitor cells, biological glues for enhanced bonding 
of reparable tears, partial and total tissue engineered 
meniscus replacement. None of these approaches has been 
completely successful and can be considered suitable for 
all patients, as meniscal tears require specific and patient-
related treatments depending on the size and type of lesion. 
Recent advances in cell biology, biomaterial science and 
bioengineering (e.g., bioreactors) have now the potential 
to drive meniscus regeneration into a series of clinically 
relevant strategies. In this tutorial paper, the clinical need for 
meniscus regeneration strategies will be explained, and past 
and current experimental studies on meniscus regeneration 
will be reported.
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Introduction
Once described as “functionless remnants of leg muscle 
origin” (Bland Sutton, 1897), the menisci are now 
considered crucial structures for knee stability, shock 
absorption, and nutrient distribution to the articular 
cartilage (Ahmed and Burke, 1983; King, 1936; Krause 
et al., 1976; Levy et al., 1989; Seedhom and Hargreaves, 
1979). However, their location and the extreme forces 
that the menisci can be subjected to make them frequently 
susceptible to injury, especially in contact-sport activities 
but also in sedentary young or elderly patients. Due in 
large part to the limited vascularity of the meniscus, 
which is restricted to the external third, this tissue has 
a poor healing potential (Arnoczky and Warren, 1982; 
Arnoczky and Warren, 1983). Although common in the 
past, total meniscectomy has been largely abandoned, 
for the direct relationship between meniscectomy and 
development of early osteoarthritis (Allen et al., 1984; 
Appel, 1970; Berjon et al., 1991; Ghosh et al., 1990; 
Hoch et al., 1983; Huckell, 1965; Jackson, 1968; Lufti, 
1975; Northmore-Ball and Dandy, 1982; Voloshin and 
Wosk, 1983). Partial meniscectomy is still indicated if 
the lesion cannot be satisfactorily sutured (Sommerlath, 
1991; Shelbourne and Carr, 2003). Regenerative medicine 
holds a great potential for restoring form and function of 
meniscal fibrocartilage. Specific considerations must be 
given to the type of cells necessary, the scaffold, and the 
physical forces within the microenvironment in which 
the meniscus is located. For these reasons, new strategies 
involving the use of bioreactors seem to be promising for 
the development of engineered meniscus tissue.
 In this review, we will give an overview on the 
potential of research for meniscus regeneration, and 
provide a perspective, from the clinician’s standpoint, for 
designing future regenerative strategies.
Current perspectives on meniscus structure, lesions 
and treatment
Anatomy, composition and function
The menisci are two semilunar or C-shaped fibrocartilage 
structures located medially and laterally between the 
femoral condyles and tibial plateau (King, 1936). They 
are crucial structures for knee joint homeostasis. Their 
function is to deepen the articular surfaces of the tibial 
plateau to better accommodate the condyles of the femur, 
providing knee stability, shock absorption, lubrication, 
proprioception and load distribution during motion. In 
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fact, in cross section, they appear as wedge-shaped and 
slightly concave on the femoral surface and have a thick 
external region. Together, the two menisci cover about two-
thirds of the tibial plateau. The menisci are held in position 
through the attachments to the joint capsule and ligaments 
surrounding the knee (Bland-Sutton, 1897; King, 1936; 
Setton et al., 1999; Renstrom and Johnson, 1990). These 
attachments maintain correct positioning of the meniscus 
during radial and anteroposterior displacement of the knee 
and provide crucial blood supply to the peripheral regions 
of the meniscus.
 Unlike the articular cartilage, the menisci possess 
an intrinsic innervation, which is related to joint 
proprioception (O’Connor and McConnaughey, 1978; 
Wilson et al., 1969). It is scarce in the body region but 
well represented in the anterior and posterior horns. It 
has been postulated that they are activated during flexion 
and extension of the knee, providing the central nervous 
system with information regarding joint position thus 
contributing to a reflex arc that stimulates protective or 
postural muscular reflexes (O’Connor and McConnaughey, 
1978; O’Connor, 1984). Regarding vascularisation, the 
human medial meniscus is vascularised in the outer 10-
30 %, while the lateral meniscus is vascularised in only the 
outer 10-25 % of its width (Arnoczky and Warren, 1982). 
These vascularised outer regions have greater propensity 
Fig. 1. Anterior horn, young pig, double 
immunofluorescence of proliferating 
cell nuclear antigen (PCNA) and 
collagen type I staining: in the inner 
(A), middle (B) and outer (C) zone. A 
strong immunopositivity of collagen 
type I fibres (red colour) is evident with 
no differences in the three zones, while 
the proliferating cells (PCNA, green 
colour) revealed a higher degree in the 
outer zone (C), followed by the middle 
(B) and then by the inner one (A). Scale 
bar 20 mm.
inner
centre
outer
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to heal when stabilised with sutures or anchors than the 
inner avascular regions. At the microvascular level, a 
capillary plexus that originates in the joint capsule and 
synovial tissues surrounding the joint supplies the menisci 
(Arnoczky and Warren 1982; Renstrom and Johnson, 1990; 
Cooper et al., 1990; Cooper et al., 1991). Additionally, 
the limited vascularity of the meniscus probably has a 
negative effect on the ability to recruit cells to a lesion 
for normal wound repair. This may be especially true for 
the nonvascular inner regions. Regarding biochemical 
composition, about 70-75 % of the wet weight of the 
meniscus consists of water (Arnoczky et al., 1988; Adams 
and Hukins, 1992; Ghosh and Taylor, 1987; McDevitt and 
Weber, 1990). The dry weight is comprised of 60-70 % 
collagen, 1 % proteoglycans, and 8-13 % non-collagenous 
proteins such as elastin. Collagens are primarily type I 
(90 %) (Fig. 1) with smaller amounts of II, III, V, and 
VI (Adams and Hukins, 1992; McDevitt and Weber, 
1990). The collagen fibres are predominantly oriented 
circumferentially, with some radially oriented fibres (Fig. 
2). This may be related to the mechanical forces which 
act on the menisci. At the meniscal surface, a collagen 
fibrillar network, woven into a mesh-like matrix, has been 
identified. The meniscus has elastin fibres throughout that 
bridge the collagen fibres. There are also inhomogeneities 
in tissue composition from the peripheral vascular regions 
to the inner avascular regions. This is appreciated by the 
histological appearance of the inner portion that resembles 
articular cartilage, whereas the outer portions are more 
fibrocartilage-like. Similarly, the superficial portion of 
the meniscus has an appearance similar to fibrous tissues. 
Regarding cell types, cells in the superficial layers of the 
tissue are fusiform, whereas those located in the deeper 
zones are more polygonal. Cell morphology also changes 
from the inner avascular region, where the cells are nearly 
indistinguishable from articular chondrocytes, to the outer 
vascular regions, where the cells are more fibroblast-like. 
Although the cells share many morphologic similarities 
to articular chondrocytes, they predominantly produce 
type I collagen. Thus, the cells are most often referred to 
as fibrochondrocytes and have a complex developmental 
origin (McDevitt et al., 1992; Hyde et al., 2008).
 In all, the material properties of the various regions of 
the meniscus are determined largely by the composition 
and microstructure of the tissue. These properties are 
highly anisotropic and different in compression and 
tension. They also vary considerably, depending on the 
depth and circumferential location of the force in the 
tissue (Mow et al., 1992). Approximately 50 % of the 
compressive load is transmitted through the menisci as 
the knee goes to extension, while the load can increase 
to as much as 85 % in flexion (Ahmed and Burke, 1983). 
In humans, the medial meniscus bears about 50 % of 
load whereas the lateral meniscus bears as much as 70 % 
(Walker and Erkman, 1975). Under normal physiologic 
loading, the meniscus experiences large tensile and shear 
stresses as well as compressive stress. Under loaded 
conditions the meniscus is not only subjected to a vertical 
force to the inner portions, but there is also a radially 
directed force applied to the concave surface pushing the 
meniscus outward (King, 1936, Shrive et al., 1978). These 
high mechanical requirements make the meniscus a crucial 
player in knee homeostasis and represent the rationale for 
a regenerative approach to meniscal lesions.
Meniscal lesions
In the early years of meniscal surgery, it was the gold 
standard to entirely excise the injured meniscus. Since 
then, after recognising that a total or subtotal meniscectomy 
inevitably leads to development of osteoarthritis within 
5-10 years after surgery, it was advocated that as much 
meniscus tissue as possible should be preserved (McGinity 
et al., 1977). Only the meniscus tissue which is identified 
as unrepairable should be excised (McGinity et al., 1977). 
As a matter of fact, during the last decades, profound 
knowledge of the meniscus function has been established 
(Wojtys and Chan, 2005) and the importance of the 
integrity of the menisci for the homeostasis of the knee 
joint has been recognised and highlighted by a number of 
clinicians and researchers (Dye, 1996; Arnold et al., 2012).
Fig. 2. Schematic diagram of 
the ultrastructure of collagen 
fibres of the meniscus. The 
large collagen fibres on the 
interior of the tissue have a 
predominant circumferential 
orientation.  The fine fibres 
of the surface layer have no 
preferred orientation. Within 
the interior of the meniscus 
are radially oriented collagen 
“tie” fibres.
Radial fibres Irregular superficial fibres
Circumferential fibres
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 In children, meniscal lesions are typically due to trauma 
or more frequently due to congenital meniscal variants 
such as a discoid meniscus or meniscal cysts (Hirschmann 
and Friederich, 2009). In adults, meniscal lesions are due 
to trauma, degenerative disease or a combination of both 
(Pujol and Boisrenoult, 2009; Verdonk and Verfevre, 2009). 
In contrast to meniscal lesions in children, in adults the 
meniscal injuries, which predominantly involve the medial 
meniscus, are often associated with concomitant ligament 
or cartilage lesions (Pujol and Boisrenoult, 2009; Verdonk 
and Verfevre, 2009). In addition, the lesion itself is more 
complex in adults, as the meniscus undergoes a significant 
degeneration in the course of a lifetime (Pujol and 
Boisrenoult, 2009). Not surprisingly, there is an increase 
of the incidence of meniscal lesions with increasing age 
(Pujol and Boisrenoult, 2009).
 The meniscal injuries can be classified with regards 
to the tear pattern in radial, longitudinal, horizontal, 
circumferential, and root lesions (Fig. 3) (Hirschmann 
and Friederich, 2009). It is believed that the central ⅓ of 
the meniscus (white zone) has less healing potential than 
the middle (red-white zone) and the peripheral ⅓ (red-red 
zone) (Hirschmann and Friederich, 2009).
Current surgical treatments
The treatment of meniscal lesions has evolved tremendously 
during the last decades. Numerous techniques and methods 
have been established in patients with meniscal lesions 
(DeHaven, 1990). A considerable number of patients 
with traumatic or degenerative meniscal lesions can be 
treated non-operatively. In fact, this is true for all patients 
who do not present with (i) blocking of the knee joint, (ii) 
pain non-responsive to pharmacological treatment, and 
(iii) meniscal lesions that appear to be biomechanically 
unstable. In this situation, the meniscus lesions could be 
masterly neglected. Typically, these lesions include partial 
thickness tears (< 5 mm), short radial tears (< 5 mm) and 
short full thickness vertical or oblique tears (< 5 mm). 
Some authors also prefer non-surgical treatment for most 
of the lateral meniscal lesions.
 Nowadays, a subtotal or total meniscectomy, whether 
open or arthroscopically, is only rarely performed, which 
can be attributed to the increasing awareness of the 
deleterious effect of meniscus removal (Fairbank, 1948; 
DeHaven, 1985; Noble and Turner, 1986). Thus, it is 
spared for patients with unrepairable, complex, mostly 
degenerative meniscus lesions (Noble and Turner, 1986). 
A partial medial or lateral meniscectomy often becomes 
necessary in symptomatic patients. Along with the 
increasing interest in meniscus preserving techniques and 
unconvincing results in partially meniscectomised patients, 
numerous meniscal repair procedures have been advocated 
(Rodkey et al., 2008; Han et al., 2010). Generally, these 
can be differentiated as inside-out, outside-in and all-inside 
repairs (Steenbrugge et al., 2004; Majewski et al., 2009; 
Hoffelner et al., 2011). A young patient age and recent 
injury are common indications for meniscal repair, but 
only lesions located in the vascular zone of the meniscus 
can be repaired. However, even in older patients and older 
meniscal lesions, many surgeons believe that a repair of the 
meniscus is of clinical benefit and thus should be attempted.
 To date, all-inside fixation devices can be considered as 
a valuable option for most of the patients with repairable 
meniscal lesions (Hoffelner et al., 2011). Inside-out and 
Fig. 3. Schematic diagram of different types of meniscal lesions.
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outside-in repair are good treatment alternatives for 
selected patients, in particular meniscal lesions in the 
anterior horn or corpus (Steenbrugge et al., 2004; Majewski 
et al., 2009). Importantly, although these repair devices 
have evolved, failure still does occur (Katabi et al., 2009).
 Aiming for improved healing of the meniscus, 
several different methods, including very basic ones, 
such as needling, abrasion, trephination and gluing, or 
more complicated ones, such as synovial flaps, meniscal 
wrapping or the application of fibrin clots, have been 
proposed (Jacobi and Jakob, 2009; Longo et al., 2012; 
Scordino and Deberardino, 2012).
Clinical need for regenerative strategies
Generally, a more active lifestyle in the younger but also 
older age group puts knees at a higher risk for sustaining a 
meniscal injury (Hirschmann and Friederich, 2009). All age 
groups and in particular children increasingly participate 
in more extreme, competitive or even professional sports 
(Hirschmann and Friederich, 2009). The consequence of 
this fact is that meniscal surgery is performed at a younger 
age, and less meniscus tissue is preserved for a longer 
lifetime period. In young, active patients a partial medial 
meniscectomy may be the starting point for a disturbed 
homeostasis of the knee, even if the mechanical axis is only 
slightly varus aligned (Arnold et al., 2012). This altered 
knee homeostasis and increased loading then inevitably 
leads to the development of osteoarthritis, which should 
be prevented under all circumstances. There is therefore a 
clear need for regenerative strategies in these young and 
middle aged patients (Arnold et al., 2012). This is where 
orthobiologic treatments come into play. The orthobiologic 
treatment algorithm is defined by a distinct hierarchy: 
(i) neutral leg alignment, (ii) ligamentous stability, (iii) 
meniscus integrity, and (iv) cartilage restoration. Each 
of these concepts is crucial to restore knee homeostasis 
(Arnold et al., 2012).
 In the last decade, striving for optimal restoration of 
meniscal tissue, the orthopaedic surgeon`s armamentarium 
has been enriched by the use of biocompatible meniscus 
scaffold and meniscal allograft transplantation (Efe 
et al., 2012; Monllau et al., 2011; Zaffagnini et al., 
2011; Harston et al., 2012). Some authors also even 
recommend a meniscal substitution for young athletes after 
meniscectomy, independent of their symptoms (Efe et al., 
2011; Monllau et al., 2011; Zaffagnini et al., 2011; Harston 
et al., 2012). However, despite promising short-term 
results, none of the current strategies have demonstrated 
regeneration of a functional, long-lasting meniscal tissue 
and re-establishment of a proper knee homeostasis in the 
meniscectomised knee.
Cell-free techniques
The rationale for using a cell-free biomaterial to replace part 
of the meniscus is based on repopulation of the scaffold by 
the host cells recruited from the synovium and the meniscal 
remnants, and subsequent tissue ingrowth which renders 
this approach cell-based after implantation. A mandatory 
prerequisite is the absence of both knee instability and 
malalignment. In addition, meniscal substitutes are not 
indicated in case of radial tears since their implant would 
require extensive tissue resection.
 The collagen meniscus implant (CMI) (ReGen 
Biologics, Franklin Lakes, NJ) is the first regenerative 
technique applied to meniscal tissue in clinical practice 
(Stone et al., 1992; Stone et al., 1997; Steadman and 
Rodkey, 2005; Zaffagnini et al., 2007). Since an outer 
rim of meniscal tissue is needed for CMI implantation, 
it is indicated only for partial and not total meniscus 
regeneration. Satisfactory clinical results have been 
reported (Rodkey et al., 1999), while MRI and histological 
results are controversial: (i) the CMI shrinks over time; 
(ii) it showed no histological remnants 5 to 6 years 
after implantation (Steadman and Rodkey, 2005); and 
(iii) it predominantly generates a scar tissue instead of 
fibrocartilage (Martinek et al., 2006). In a recent medium-
term follow-up, non-controlled case series involving 34 
patients, Bulgheroni et al. (2010) showed good to excellent 
clinical results after 5 years from a CMI implantation for 
a symptomatic deficiency of medial meniscal tissue. In 
particular, chondral surfaces had not further degenerated 
after placement of the CMI, and MRI signal had indicated 
a progressive maturation between 2 and 5 years after 
implantation, progressively resembling the low signal of 
a normal meniscus. Authors confirmed the tendency of 
the CMI-new tissue complex of undergoing shrinking, but 
with no generally negative effects on the clinical outcome. 
Another non-controlled case series reported significant pain 
relief and functional improvement at a minimum 10-year 
follow-up (Monllau et al., 2011). However, no negative 
controls were included in these two studies, making it 
difficult to ultimately assess the value of this procedure. 
Overall, despite the wide clinical use, no randomised, high-
quality controlled trial supports the use of this implant.
 Following several experimental studies in animal 
models for total meniscus replacement (van Tienen et 
al., 2009; Welsing et al., 2008; Hannink et al., 2011), 
polyurethanes are now being assessed as alternative 
biomaterials for partial meniscus replacement. The Actifit™ 
(Actifit, Orteq Ltd, London, United Kingdom) meniscus 
implant is a polyurethane-polycaprolactone (PU-PCL)-
based synthetic meniscal substitute intended for use in the 
irreparable, partial meniscal defects (Verdonk et al., 2009; 
Verdonk et al., 2011). Because of its polymeric nature, 
Actifit™ has a higher mechanical strength and ease of 
handling compared to CMI. On the other hand, degradation 
is expected to occur in 4 to 6 years, thus being much 
slower than that of CMI. In particular, polycaprolactone 
is degraded by hydrolysis while polyurethane is slowly 
degraded by macrophages and giant cells. The clinical 
application of this meniscal implant started recently and 
medium to long-term evidence on chondroprotection is 
not yet available. The first 12-month report of a multi-
centre, prospective clinical trial involving 52 patients 
with irreparable meniscal tear or partial meniscal loss has 
been recently published, showing tissue ingrowth into 
the scaffold at 3 months and further tissue ingrowth at 12 
months, with consistent MRI and histology data (Verdonk 
et al., 2011). Another recently published study, involving 
10 patients with a 12-month follow-up, showed the safety 
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of this scaffold for the treatment of symptomatic patients 
with segmental medial meniscus defects. (Efe et al., 2012). 
However, only when more medium-to-long term evidence 
about its safety and effectiveness will be available, could 
Actifit™ be considered a valid alternative for partial 
meniscal replacement.
 In conclusion, meniscal implants demonstrated good 
short- to medium-term clinical results, but no evidence 
supports their use routinely in clinical practice and no 
study reported convincing long-term protection from joint 
degeneration to date.
Meniscal transplantation
Meniscus represents the ideal tissue for transplantation: 
vascular anastomosis is not needed and its cells are 
immunoprivileged because of the avascular environment. 
As a consequence, surgery is less demanding and 
immunosuppressive therapy is not needed (Jackson et 
al., 1992). Meniscal transplantation is actually the only 
biologic option available for the symptomatic, totally 
meniscectomised, non-osteoarthritic, stable and well-
aligned knee (Verdonk et al., 2007; Lubowitz et al., 
2007). On the other hand, although this technique is not 
new (Milachowski et al., 1989), the long-term effects, 
especially in terms of chondroprotection and prevention of 
osteoarthritis, still remain to be proven (Wirth et al., 2002). 
Limitations of this procedure include tissue availability, 
risk of immune reaction, risk of disease transmission, and 
graft sizing (Lubowitz et al., 2007).
 Regarding the type of allograft, four have been used: 
cryopreserved, deep-frozen (fresh-frozen), fresh, and 
lyophilised (freeze-dried) (Cole et al., 2003; Lubowitz 
et al., 2007). Fresh grafts present the advantage of being 
rich in viable cells and this has been demonstrated to 
improve mechanical integrity following transplantation, 
determining a lower failure rate of the procedure compared 
to those of deep-frozen and lyophilised grafts (Siegel 
and Roberts, 1993; Verdonk et al., 2005). Despite this 
advantage, no evidence supports the increased expense 
related to these procedures (Verdonk et al., 2005; Lubowitz 
et al., 2007). Moreover, an animal study demonstrated that 
donor cells are replaced by host cells, so that the need of 
a viable graft has been questioned (Jackson et al., 1993). 
However, donor DNA remains detectable in human patients 
for a longer period than in the animal models (Verdonk et 
al., 2005).
 According to current literature, indications to this 
technique are not yet defined; however, it seems to be 
indicated in two clinical scenarios (Verdonk et al., 2007; 
Lubowitz et al., 2007): (i) young patients (<50 years of age) 
with a symptomatic, meniscus-deficient compartment in 
a stable joint, without malalignment and with only minor 
chondral lesion (no more than grade 3 according to ICRS 
score); and (ii) patients with an ACL-deficient knee which 
sustained a medial meniscectomy. In the second group of 
patients, meniscal transplantation is performed together 
with ACL reconstruction as it grants an improved stability 
compared to that obtained with ACL reconstruction 
alone (Barber, 1994). A further clinical scenario has been 
advocated by some authors (Johnson and Bealle, 1999): 
prophylactic transplantation in young, sportive patients 
who had complete meniscectomy, before the onset of 
symptoms. However, such an aggressive approach is not 
routinely recommended to date (Lubowitz et al., 2007).
 A recently published meta-analysis, analysing 44 
published clinical trials with at least 6 months follow-up in 
the last 26 years, concluded that this procedure should not 
be considered experimental surgery anymore, but, instead, 
it is a safe and effective technique allowing patients to 
resume high levels of activity and work, at least, as a long-
term ‘‘bridging’’ procedure before arthroplasty (Elattar et 
al., 2011). Actually, a number of orthopaedic surgeons have 
reported clinical and radiological mid-term results (Kim 
et al., 2012; Lee and Caborn, 2012). However, fixation of 
the allograft, whether soft-tissue or bone plug associated, 
remains a significant source of failure (Hommen et 
al., 2007). Additional problems of meniscal allograft 
transplantation are the limited availability, the technically 
demanding surgical procedure, and the frequent mismatch 
of graft and host tissue (Shaffer et al., 2000). Xenografts 
have only been used in animal or cadaver studies till now, 
but might become an interesting treatment alternative 
(Jiang et al., 2012).
 In conclusion, meniscal transplantation allows for good 
short-to-intermediate term results in selected patients, 
while it is not yet demonstrated whether this technique 
provides long term protection from joint degeneration 
(Wirth et al., 2002).
Research potential for meniscus repair and 
regeneration: from cell therapy to tissue therapy
Currently, a number of experimental approaches are 
addressing the issue of meniscal regeneration. In particular, 
researchers work on the development of different potential 
regenerative solutions for different clinical scenarios 
requiring different surgical treatments. These can be 
summarised as follows: (i) improved biological bonding in 
case of reparable tears; (ii) partial meniscus regeneration, 
to restore the tissue removed after meniscectomy; and 
(iii) total meniscus regeneration, when sub- or total 
meniscectomy is performed. In the following sections the 
mainstays of tissue engineering (cells, growth factors and 
scaffolds), with respect to meniscus regeneration, and the 
experimental strategies combining them will be reported.
Cell sources
Several adult differentiated cells from various tissues have 
been used in tissue engineering studies. In this chapter, 
we will discuss the potential for meniscus regeneration of 
meniscus cells (MC), articular (AC), costal (CC) and nasal 
chondrocytes (NC), bone marrow-derived mesenchymal 
stem cells (MSC), synovial membrane-derived MSC and 
embryonic stem cells (ESC).
 From a clinical standpoint, the ideal tissue for cell 
harvesting is the meniscectomised meniscus itself, as no 
additional morbidity is produced. Nakata et al. (2001) 
investigated the potential for tissue engineering approaches 
of MC isolated from meniscectomised menisci. In this 
study, authors expanded in vitro human MC and seeded 
them on a collagen scaffold with success, demonstrating 
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the feasibility of obtaining an adequate number of cells 
from small meniscal specimens and of seeding them 
on biologic scaffolds. In a more recent study, Baker et 
al. (2009) demonstrated that expansion and seeding of 
meniscal debris-derived cells onto nanofibrous scaffolds 
led to engineered constructs with mechanical properties in 
tension approaching native tissue levels. However, many 
patients candidate to meniscus allotransplantation have 
already undergone total meniscectomy and an alternative 
cell source is, therefore, needed. This feature limits the use 
of this cell type only to meniscus repair and regeneration 
approaches.
 Articular cartilage is an attractive cell source also 
for meniscus tissue engineering since it can be easily 
harvested from non-weight bearing areas and AC can be 
enzymatically isolated and used for tissue engineering 
strategies. Marsano et al. (2007) investigated and compared 
the potential for meniscus tissue engineering of inner 
meniscus cells, fat pad cells, synovial membrane cells and 
AC in pellet culture, in scaffold, and in nude mice culture. 
The authors reported the formation of meniscus-resembling 
tissue by AC only, while in the samples obtained with the 
other cell types, the glycosaminoglycan (GAG) content 
was negligible and no collagen type II was detected. This 
is consistent with all the previous works reporting the AC 
capability of accumulating large quantities of cartilaginous 
matrix. Interestingly, AC deposited also collagen type I and 
IV, the latter typically present in the outer vascularised area 
of the meniscus. In addition, the phenotype of AC may 
adapt upon exposure to specific regimens of physical forces 
in order to generate a tissue structure resembling that of 
the human meniscus (Marsano et al., 2006), making them 
an attractive cell type for meniscus tissue engineering.
 Interest has recently focused on the potential of CC 
for knee and temporomandibular joint meniscus tissue 
engineering (Johns and Athanasiou, 2008; Anderson and 
Athanasiou, 2009). Importantly, costal cartilage represents 
a clinically-compliant cell source since the harvest can 
be abundant while leaving little donor site morbidity. 
These cells display also a high synthetic activity after in 
vitro expansion, being able to deposit large quantities of 
fibrocartilaginous matrix with GAGs, collagen type II and 
type I (Johns and Athanasiou, 2008). This feature can be 
further manipulated by co-culturing CC with other cell 
types in order to create a spectrum of fibrocartilaginous 
engineered tissues. In particular, the collagen I/II ratio 
could be modified by cell types used in co-culture and 
serum presence in order to span the whole native range 
(Hoben and Athanasiou, 2008).
 Thanks to their high chondrogenic potential, ease 
of harvesting, lower inter-individual variability, faster 
proliferation and positive response to load, NC have 
been extensively studied for cartilage tissue engineering 
purposes (Scotti et al., 2012; Candrian et al., 2008; Tay 
et al., 2004). In particular, their capability to adapt to a 
joint-like environment (low-oxygen tension, inflammatory 
environment and load) makes them a suitable cell source 
for joint regeneration (Scotti et al., 2012; Candrian et al., 
2008). However, to date there is no report in the literature 
of NC-based approaches for meniscus regeneration.
 Stem cells are characterised by self-renewal capacity 
and multilineage differentiation potential to distinctive 
end-stage cell types of mesenchymal tissues, such as bone, 
cartilage, muscle, tendon/ligaments and fat, in response 
to environmental cues (Caplan, 1991; De Bari et al., 
2007). They can be extensively expanded in vitro while 
maintaining their differentiation potential and subsequently 
cryopreserved. In addition, MSC have a natural capacity 
to home to injured tissues and to participate to tissue 
healing. This second feature seems particularly interesting 
as MSC not only provide a substrate for regeneration but 
also secrete paracrine factors that enhance the potential for 
tissue repair, acting as “trophic mediators” (Caplan, 2007). 
MSC have been isolated from several tissues, including 
bone marrow (Pittenger et al., 1999), periosteum (De Bari 
et al., 2001a), synovial membrane (De Bari et al., 2001b) 
and adipose tissue (Zuk et al., 2002).
 Bone marrow is the main cell source for adult MSC 
because of its ease of harvest with limited morbidity and, 
therefore, MSC have been used in a myriad of experimental 
studies and also in some clinical trials. Adult bone marrow 
contains both haematopoietic stem cells (HSC) and MSC 
(Caplan, 1991; Herzog et al., 2003). HSC and MSC 
can be distinguished by the expression of cell surface 
antigens, as MSC typically lack antigens such as CD45 
and CD34 that usually identify HSC (Herzog et al., 2003). 
However, the number of progenitor cells present in human 
fresh bone marrow biopsies is very low (about 0.01 % of 
the total mononucleated cells), further decreasing with 
donor age and thus requiring in vitro cell expansion to 
reach an adequate cell number for regenerative purposes 
(Muschler et al., 2001). Another possible drawback of 
bone marrow-derived MSC, limited to articular cartilage 
and meniscus regenerative strategies, is that they seem to 
retain osteogenic propensities, through an endochondral 
pathway, as the default differentiation route (Muraglia 
et al., 2000; Scotti et al., 2010). As a consequence, 
chondrocyte hypertrophy and subsequent vascularisation 
and mineralisation can impair the final quality of the newly 
formed tissue. However, bone marrow-derived MSC still 
remain the mainstay of stem cell-based approaches in 
orthopaedic clinical practice.
 Another attractive cell source for the orthopaedic 
surgeon is represented by the synovial membrane, since 
it can be easily harvested in both open and arthroscopic 
surgery. Synovial membrane-derived MSC have been 
described by De Bari et al. (2001b) reporting a progenitor 
nature with remarkable self-renewal capacity. Recently, 
work has described the superior capacity of synovial 
membrane-derived MSC to generate cartilaginous tissues 
compared to MSC obtained from other tissues (Sakaguchi 
et al., 2005). On the other hand, a following report of 
De Bari et al. (2004) showed that these cells failed to 
produce in vivo a stable and differentiated cartilaginous 
tissue, undergoing cell death and neoangiogenesis. This 
suggests that in vitro pre-differentiation is not sufficient 
to guarantee stable lineage commitment and restriction 
of differentiation. However, synovial membrane-derived 
MSC are still a valuable and promising cell type for tissue 
engineering, and different approaches, such as intra-
articular delivery, are currently being investigated.
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 The use of ESC is also advocated for meniscus tissue 
engineering strategies (Koay and Athanasiou, 2009; Hoben 
et al., 2008). Despite the concerns raised about ethical 
issues, their safety, since they tend to form tumours once 
implanted unless they are pre-differentiated, and since they 
are immunogenic, their highly pluripotency makes them an 
attractive cell type for the regeneration of various tissues 
(De Bari et al., 2007). While the issue of the oncogenic 
potential is currently being addressed by improving in 
vitro ESC commitment and culture, the immunogenicity 
could be overcome by implementing large cell banks with 
genotyped ESC cell lines (De Bari et al., 2007). This would 
theoretically allow transplanting a large number of HLA-
matched recipients with these cells. However, a possible 
clinical application of ESC for non-lethal diseases is still 
to be planned.
Intra-articular delivery of MSC
An attractive strategy for joint regeneration is intra-
articular injection of progenitor cells that can participate 
to and enhance tissue regeneration. This approach presents 
several advantages: (i) it is easy to be performed in an 
outpatient setting with minimum morbidity; (ii) it can 
be used to deal with either single lesions or degenerative 
diseases; (iii) it works in two directions, delivering cells 
that can both actively regenerate the damaged tissues and 
secrete anti-inflammatory and trophic factors that can re-
establish joint homeostasis according to Caplan (Caplan, 
2007; Caplan and Correa, 2011); (iv) it can be repeated; 
and (v) it minimises systemic diffusion of the implanted 
cells (Horie et al., 2009).
 A first report of this strategy has been performed by 
Murphy et al. (2003) by injecting bone marrow-derived 
MSC in suspension with sodium hyaluronan in an 
osteoarthritis (OA) goat model. In this work, the authors 
showed successful cell survival and engraftment in the 
regenerated medial meniscus which was completely 
excised, together with the ACL, to determine OA. 
Importantly, this involvement of the injected MSC in 
the regenerated meniscus resulted in protection from 
OA progression at the latest experimental time point. 
However, the number of injected cells in the regenerated 
tissue was too low for being responsible of the massive 
tissue regeneration, while, on the other hand, MSC had 
more likely trophically enhanced the regeneration of the 
meniscus.
 In a more recent work, Horie et al. (2009) investigated 
the potential for meniscus regeneration of intra-articularly 
injected synovial membrane-derived MSC in a rat massive 
meniscal defect model. The authors not only demonstrated 
active participation of the injected MSC in the regeneration 
process, adhering to the injured sites and synthesising new 
tissue, but also showed with in vivo imaging analysis that 
the injected cells do not mobilise out of the injected joint. 
This is a crucial safety issue with respect to a possible 
clinical application of this approach. Another interesting 
finding in this work is that the authors could detect MSC 
activity in the knee joint up to 28 d after the injection but 
not at a longer time point. This can be explained by the 
fact that, after triggering tissue regeneration, most cells die 
while only a few remain in the newly formed tissue. This 
is further evidence supporting the hypothesis of MSC as 
trophic factor releaser for tissue repair. However, stronger 
evidence, possibly obtained with more relevant large 
animal models, should be provided prior to considering 
this approach as an option with clinical relevance.
Growth factors and gene therapy
To date, the effect of many growth factors (GF) on 
meniscal fibrochondrocytes or meniscal explants has been 
investigated (Table 1), since matrix synthesis enhancement 
and metalloproteinase inhibition are crucial mechanism to 
be addressed for meniscus repair and tissue engineering 
(Buma et al., 2004). In particular, transforming growth 
factor β (TGF-β) demonstrated a promising effect in term 
of stimulation of GAGs and biglycan production by MC 
in vitro (Collier and Gosh, 1995). However, it remains to 
be demonstrated whether TGF-β stimulation may lead 
to a tissue engineered meniscus more similar to native 
meniscus or to a more efficient repair, because collagen, 
rather than GAGs, seems to be important for meniscus 
function (Buma et al., 2004). Other GF demonstrated 
to have a trophic effect on meniscal fibrochondrocytes 
are: hepatocyte growth factor (HGF); insulin-like growth 
Table 1. Growth factors of relevance for meniscus tissue engineering.
Growth factor Effect on meniscal cells or tissue References
FGF-2 Enhance cell proliferation in monolayer culturesEnhance collagen synthesis in cell-seeded scaffold
(Marsano et al., 2007)
(Pangborn and Athanasiou, 2005)
TGF-β1
Enhance cell proliferation in monolayer culture
Enhance SMA expression
Enhance collagen and proteoglycan synthesis
Enhance cell proliferation on a PU scaffold
(Marsano et al., 2007)
(Zaleskas et al., 2001)
(Collier and Ghosh, 1995, Pangborn and Athanasiou, 2005)
(de Mulder et al., 2011)
IGF-1
Main anabolic factor of cartilage
Enhance collagen synthesis in cell-seeded scaffold
Stimulate cell migration
(Buma et al., 2004)
(Pangborn, 2005)
(Bhargava et al., 1999)
HGF Improve vascularisation of engineered tissue (Hidaka et al., 2002)
PDGF-BB
Enhance cell proliferation in vitro
Decrease SMA expression
(Marsano et al., 2007)
(Zaleskas et al., 2001)
BMP-2
BMP-7 (OP-1)
Enhance cell proliferation
Stimulate cell migration
Enhance proteoglycan synthesis 
(Bhargava et al., 1999)
(Bhargava et al., 1999)
(Lietman et al., 2003)
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factor 1 (IGF-1); fibroblast growth factor 2 (FGF-2); 
platelet-derived growth factor (PDGF); and certain bone 
morphogenetic proteins (BMPs) (Buma et al., 2004, 
Pangborn and Athanasiou, 2005). In particular, HGF was 
demonstrated to enhance vascularisation of engineered 
meniscal fibrochondrcyte-PGA constructs, but without 
improving mechanical properties (Hidaka et al., 2002), 
and IGF-1 is one of the main anabolic factors of articular 
cartilage (Schmidt et al., 2006). As the outer part of the 
meniscus is vascularised (Clark and Ogden, 1983) and the 
inner region is characterised by an ECM partially similar to 
that of the articular cartilage (Chevrier et al., 2009), the use 
of these two GF could be a promising combination to be 
evaluated. Another interesting finding was the modulation 
of smooth muscle actin (SMA) expression by TGF-β1 and 
PDGF-BB (Buma et al., 2004). A study demonstrated that 
TGF-β1 increases SMA expression and cell contraction 
while PDGF-BB has the opposite effect: investigation of 
the mechanisms underlying SMA-enabled contraction may 
be crucial for cell expansion and differentiation (Zaleskas, 
2001).
 Recent advances in gene therapy techniques 
have demonstrated the feasibility of gene transfer to 
musculoskeletal tissues (Evans and Robbins, 1999; 
Madry et al., 2003; Madry et al., 2004). GF gene transfer 
is an attractive option to enhance meniscal repair, and 
this has been demonstrated both in vivo and in vitro with 
different approaches (Goto et al., 1999; Hidaka et al., 
2002; Martinek et al., 2002; Nakata et al., 2001). Several 
vectors have been used: retroviral, adenoviral and adeno-
associated; each of them presenting peculiar characteristics 
(Madry et al., 2004; Goto et al., 1999; Hidaka et al., 
2002). Retroviral vectors have been widely used in gene 
therapy studies, nevertheless they need actively replicating 
cells as target, while fibrochondrocytes do not duplicate 
in vivo, and they can theoretically cause cancer, through 
insertional mutagenesis. Although the first limitation can 
be overcome by the use of lentiviral vectors, that can 
transduce also non-dividing cells, safety concerns make 
them unattractive to orthopaedic researchers who deal 
with non-lethal disorders (Madry et al., 2004; Daniel and 
Smith, 2008). Adenoviral vectors are immunogenic and do 
not integrate into the host cell genome; as a consequence 
they prevent the risk of cancer but they do not grant long-
term transgene expression (Madry et al., 2004; Steinert et 
al., 2007). Adeno-associated vectors (AAV) can carry only 
a small amount of DNA; on the other hand, they are not 
immunogenic and not pathogenic, and they can transduce 
non-dividing cells: these features make them very attractive 
for orthopaedic use, making them a promising option for 
the treatment of musculoskeletal diseases (Madry et al., 
2004; Cucchiarini et al., 2009).
 Following the first studies with marker genes (Madry 
et al., 2004; Goto et al., 1999), the main GF used for 
gene transfer to the meniscus to date are HGF (Hidaka 
et al., 2002), TGF-β1 (Steinert et al., 2007), and FGF-2 
(Cucchiarini et al., 2009). HGF induced blood vessel 
formation in an engineered construct made of meniscal 
fibrochondrocytes seeded onto a PGA scaffold, improving 
the potential for integration and metabolic exchanges of 
the engineered implant (Hidaka et al., 2002). TGF-β1 
gene transfer enhanced the cellularity and the deposition 
of proteoglycans and collagen type 2 both in monolayer 
and in 3D cultures (Steinert et al., 2007; Goto et al., 2000). 
On the other hand, of importance are the consequences of 
ubiquitous overexpression of TGF-β1, as it determines 
severe joint fibrosis and detrimental systemic effects (Mi et 
al., 2003; Steinert et al., 2007). Consequently, a localised 
delivery of TGF-β1 to the site of lesion is mandatory. 
FGF-2 transfer through an AAV resulted in increased 
proliferation, survival and metabolic activity of human 
MC in vitro, in a three-dimensional in vitro culture system, 
and in situ in a human meniscal defect model (Cucchiarini 
et al., 2009). This study proved that direct application of 
AAV vectors has the potential to induce healing in the 
injured meniscus. However, since no complete healing was 
achieved and since proliferation is just one player of tissue 
regeneration, additional studies are required to assess the 
optimal gene delivery strategy for meniscus regeneration.
 Overall, the application of gene transfer techniques 
to meniscus regeneration holds some potential. However, 
several variables have to be still assessed, such as i) the 
modality of transduction (modification of many cell types, 
transduction of whole tissues, intra-articular injection); ii) 
the ideal combination of genes to be transferred; or iii) the 
most efficient cell type, when transfected cells are used.
Scaffolds
A biomaterial used as scaffold for meniscus tissue 
engineering purposes should present many features. 
In particular, the ideal meniscal scaffold should be (i) 
“cell-instructive”, promoting cell differentiation and 
proliferation if cell-seeded, or cell migration if cell-free; 
(ii) “biomimetic”, mimicking architecture, tribology and 
mechanical features of the native meniscus; (iii) resilient 
and resistant to withstand mechanical forces acting in 
the joint while cells produce ECM; (iv) biocompatible, 
not evoking any foreign-body reaction also with its 
degradation products; (v) slowly biodegradable allowing 
to be gradually replaced by biologic tissue; (vi) open, with 
high porosity, allowing diffusion of nutrients and catabolic 
substances; and (vii) easy to handle, to be sutured and to 
be implanted by the surgeon (Arnoczky, 1999; van Tienen 
et al., 2009).
 With the ultimate goal of designing the ideal scaffold 
for meniscus tissue engineering, many biomaterials have 
been evaluated both natural and synthetic (Buma et 
al., 2004) (Table 2). Natural materials used to date are: 
periosteal tissue (Walsh et al., 1999); perichondral tissue 
(Bruns et al., 1998); small intestine submucosa (SIS) 
(Cook et al., 1999); acellular porcine meniscal tissue 
(Stapleton et al., 2008); and bacterial cellulose (Bodin et 
al., 2007). While these tissues have high biocompatibility, 
some of them cannot be employed for tissue engineering 
techniques as they do not allow varying structure geometry 
and initial mechanical properties (Buma et al., 2004). A 
more attractive strategy is represented by isolated tissue 
components as collagens and proteoglycans (Mueller et 
al., 1999; Pabbruwe et al., 2010). They maintain the high 
biocompatibility of the whole tissues while allowing to 
create custom-made scaffold with definite pore dimension 
and geometry and, consequently, biomechanical features. 
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However, these scaffolds have usually low biomechanical 
properties and are characterised by rapid biodegradation, 
thus not long enough to be completely replaced by the 
newly formed tissue (Buma et al., 2004).
 On the other hand, polymer materials can be 
manufactured in custom-made shapes of any geometrical 
structure, porosity and biomechanical properties, according 
to the characteristics of the host tissue and the seeded cells. 
In particular, it has been shown that for optimal ingrowth 
and incorporation of a meniscal scaffold, macropore sizes 
must be in the range of 150-500 μm (Klompmaker et al., 
1993). The biodegradation rate can be also modulated 
by acting on polymer composition. To date, the most 
used synthetic polymers are: polyglycolic acid (PGA) 
(Vacanti et al., 1991); poly(L)lactic acid (PLLA) (Freed 
et al., 1993); poly-(lactic-co-glycolic acid) (PLGA) 
(Kang et al., 2006); polyurethane (Heijkants et al., 2004; 
van Tienen et al., 2002); polyester carbon (Wood et al., 
1990); polytetrafluoroethylene (Toyonaga et al., 1983); and 
polycaprolactone (PCL) (Lebourg et al., 2008). Possible 
drawbacks of the use of synthetic polymers for tissue 
engineering purposes are the low cell-adhesive properties, 
since they lack the cell-adhesion domains normally present 
on natural macromolecules, and the even mild foreign-body 
reaction occurring after implantation (Cao et al., 1998; 
Welsing et al., 2008). In order to improve biocompatibility 
and biodegradability of polymer scaffolds, the use of a 
biopolymer, such as silk fibrous protein, has been proposed 
(Mandal et al., 2011a; Mandal et al., 2011b).
 An alternative attractive strategy is represented by the 
use of hydrogel materials. Their semi-liquid nature allows 
engineering anatomic geometries derived from medical 
imaging techniques, such as computed tomography or 
magnetic resonance, by the use of custom-printed moulds 
(Ballyns et al., 2008). Promising results were reported 
with alginate (Ballyns et al., 2010; Ballyns et al., 2008) 
and polyvinyl alcohol (PVA) (Kobayashi et al., 2003; 
Kobayashi et al., 2005). However, despite their wide 
implementation in cartilage tissue engineering they have 
been hardly utilised for meniscus engineering.
 Briefly, both natural materials and synthetic polymers 
present peculiar advantages and disadvantages. Most 
importantly, no biomaterial demonstrated to be superior 
to the others in terms of supporting cell proliferation and 
Table 2. Biomaterials of relevance for meniscus tissue engineering.
Biomaterial Summary of results References
Collagen CMI scaffolds seeded with autologous fibrochondrocytes. Macroscopic and histological improvement of the transplants compared to cell-free CMI. Martinek et al., 2006
SIS
A cell-free SIS implant demonstrated better results than meniscectomy 
with less cartilage damage. Another study reported the potential of SIS as 
a scaffold to support co-culture of synovial membrane-derived MSC and 
meniscal cells.
Cook et al., 2006
Tan et al., 2010
PCL
PCL scaffold with defined nanofibres alignment determines better neotissue 
organisation and mechanical properties.
Baker et al., 2007
Baker et al., 2010
Baker et al., 2012
Hyaluronan-
PCL
Partial and total meniscus replacement, both cell-free and cell-seeded, in 
ovine models. 4 months follow up. Good tissue ingrowth/formation. Better 
results for cell-seeded scaffolds also in terms of chondroprotection.
Chiari et al., 2006
Kon et al., 2008
Polyurethane-
PCL
Cell-free total meniscus implant demonstrated good integration and 
fibrovascular tissue ingrowth in a 2-year follow-up study in dogs. Mild 
foreign body reaction was noticed. Not better chondroprotection compared 
to meniscectomised knees.
Hannink et al., 2011
Welsing et al., 2008
Heijkants et al., 2005
Heijkants et al., 2004
van Tienen et al., 2009
PGA-PLGA
Total meniscus PLGA implant seeded with allogeneic meniscal cells in a 
rabbit model. Positive histological results at 36 weeks. Biochemical and 
biomechanical improvement of the neotissue over time.
Kang et al., 2006
Silk Tri-layered silk fibrous protein scaffold seeded with human fibroblasts and chondrocytes or MSC showed cell growth with aligned ECM deposition.
Mandal et al., 2011a
Mandal et al., 2011b
Carbon
Replacement of the whole meniscus with a polyester-carbon cell-free 
implant in a rabbit model. Better results than meniscectomised, untreated 
knees.
Wood et al., 1990
Hyaluronan-
gelatin
Partial meniscus regeneration with a 70 % HA-30 % gelatin scaffold seeded 
with autologous MSC in a rabbit model. Better results than with cell-free 
scaffold. A second study showed better results for unpassaged MSC.
Angele et al., 2008
Zellner et al., 2010
PVA
Total meniscus replacement with cell-free implant in rabbit model with 
2-year follow up. Successful chondroprotection. No regeneration of 
meniscal tissue. Concerns about long-term durability, safety and fixation 
method.
Kobayashi et al., 2003
Kobayashi et al., 2005
Agarose In vitro engineering of critically sized meniscal constructs with bovine and 
ovine fibrochondrocytes in a mixing bioreactor.
Ballyns et al., 2008
Ballyns et al., 2010
Scaffold-free
Self-assembled engineered meniscal tissues, obtained with co-cultures 
of fibrochondrocytes and MSC in ring-shaped moulds, displayed better 
morphological and mechanical features than cell-loaded PGA scaffolds.
Aufderheide and Athanasiou, 2007
Huey and Athanasiou, 2011
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tissue growth. No clear advantage was also evident in 
term of biomechanical properties suitable for implantation 
in the knee joint. A possible solution is represented by 
combining them, in order to couple the high cell-affinity 
and biocompatibility of natural polymers with the superior 
mechanical strength and ease of being tailored of synthetic 
polymers. This strategy has been recently evaluated in two 
large animal studies on partial and total meniscus tissue 
engineering with a hybrid material composed of PCL and 
hyaluronic acid (HA) with promising results (Chiari et al., 
2006; Kon et al., 2008).
 In the following sections we will discuss different 
experimental studies for partial and total meniscus 
engineering performed to date and having a potential 
clinical exploitation.
Cell-based bonding studies
As long as lesions occurring in the inner “red-white zone” 
and “white-white zone” do not allow a biological repair to 
be achieved, even after stabilisation, cell-based strategies 
have been evaluated in order to enhance the bonding of a 
torn meniscus. From a clinical point of view, a tool which 
can improve the results of meniscal sutures is valuable. 
The rationale of this approach has been validated in studies 
demonstrating that isolated chondrocytes, either seeded 
onto cartilaginous (Peretti et al., 1998; Peretti et al., 1999) 
and meniscal matrices (Peretti et al., 2001), PLGA scaffold 
using dynamic conditions (Yoo et al., 2011; or embedded 
in fibrin glue (Peretti et al., 2008; Scotti et al., 2009), were 
able to bond separate pieces together. These studies were 
performed ectopically, in a subcutaneous environment 
in a nude mouse model, which is vascularised and not 
subjected to weight bearing, and therefore not suitable to 
ultimately evaluate the value of a regenerative strategy for 
the knee joint. In order to test the potential of transplanted 
chondrocytes for use as a reparative technique in lesions 
involving the human knee, further studies were performed 
in situ in a pig model (Peretti et al., 2004; Weinand et al., 
2006a; Weinand et al., 2006b). Among the animal models 
for meniscus regeneration studies (Deponti et al., 2013), 
the pig is very valuable as it has been demonstrated that the 
vascularisation of the porcine meniscus remains confined 
in the outer part of the menisci and never extends into the 
inner third of its structure (Peretti et al., 2004).
 In the first study, an allogeneic devitalised meniscal 
scaffold was chosen as a carrier for autologous chondrocytes 
in an orthotopic pig model (Peretti et al., 2004). A one-
centimetre longitudinal tear was created in the avascular 
portion of the medial meniscus at the junction of its inner 
third and outer two-thirds and the chondrocyte-seeded 
meniscal scaffold was inserted inside the lesion and 
secured by two vertical sutures. Histological evaluation 
demonstrated bonding tissue, resembling cartilaginous and 
fibrocartilaginous matrix, synthesised by the transplanted 
chondrocytes in samples from the experimental group. 
Although the repair was not uniformly complete in 
this study, the results were considered encouraging as 
good integration of the scaffold material with the native 
meniscus appeared to be present in numerous areas by the 
formation of new cartilage matrix.
 According to these results, in subsequent studies the 
potential of different allogeneic cell sources and of Vicryl 
meshes as a scaffold was evaluated, in the same orthotopic 
model as the previous study (Weinand et al., 2006a; 
Weinand et al., 2006b). The rationale of using allogeneic 
cells of different sources is that it is unlikely to obtain a 
sufficient number of healthy meniscal fibrochondrocytes 
from an injured meniscus. Additionally, Johnson et al. 
(2004) showed the healing potential of auricular and 
costal chondrocytes suspended in fibrin polymer and 
placed between articular cartilage discs, demonstrating 
the feasibility for alternative cell types to heal cartilage. 
Moreover, the harvesting of autologous cells can add 
additional trauma to the patient, while large quantities 
of cartilage cells may be obtained using allogeneic 
chondrocytes from cadaveric sources. Regarding the results 
of these studies, some degree of new tissue formation was 
found in all experimental samples, whereas none was 
found in any of the control groups. The newly formed 
tissue was uniform in all samples, having a characteristic 
fibrous tissue-like appearance. Interestingly, the length 
of the repaired lesion was highest in the auricular based 
specimens, which also demonstrated a higher overall rate of 
repair: more than 65 % of samples were repaired compared 
to more than 55 % of the articular specimens. This 
histological finding is consistent with higher biomechanical 
testing values in fracture energy, stiffness and extension 
of the tested samples. These results may also be due to 
the fact that auricular chondrocytes produce a higher 
amount of elastin than articular chondrocytes. Regarding 
the issue of using allogeneic cells, they showed a slightly 
lower complete healing rate than the use of autologous 
cells. Although cellular rejection might be expected when 
using allogeneic cells, none of the menisci repaired with 
allogeneic articular or auricular cells had evidence of 
immune rejection. Only few histiocytes were observed 
within the newly formed tissue, and these may be related 
to a foreign body reaction to the Vicryl scaffold. Possible 
explanations for the absence of an inflammatory reaction 
include the avascular environment into which the implant 
is placed and questionable expression of MHC antigens 
on the surface of the chondrocytes (Bujia et al., 1994). In 
all, these studies suggested that allogeneic cell populations 
have a potential to repair tears in the meniscus, used 
in combination with biodegradable scaffolds, and that 
auricular chondrocytes could provide complete healing. 
Moreover, the use of allogeneic cells could overcome 
the potential clinical limitations of donor site morbidity 
and inadequate cell numbers, which represent the main 
bottleneck to the clinical application of every single cell-
based strategy.
 From a surgical point of view, a suture capable to 
release in a controlled manner trophic GF or a cellular gel 
acting as a biological glue could be more manageable tools 
than a solid matrix to improve the bonding obtained with 
meniscal sutures. The first approach has been investigated 
by Kopf et al. (2010), reporting the results of a VEGF-
coated non-absorbable suture for meniscal repair in a sheep 
orthotopic model. Although very interesting, this approach 
did not improve meniscal healing, probably because of the 
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inappropriate kinetics of VEGF release. In this regard, an 
ectopic nude mouse study was performed, consisting of the 
evaluation of the potential of bonding meniscal slices by 
cellular fibrin glue (Peretti et al., 2008; Scotti et al., 2009). 
In this study, the firm gross bonding seen macroscopically 
was confirmed by the histology, as the cellular fibrin glue 
provided a microscopic bonding between the two meniscal 
slices through a fibrocartilaginous tissue. Moreover, 
penetration buds from the cellular fibrin glue to the native 
meniscal tissue were evident. This represents a positive 
finding as we had previously demonstrated that this 
characteristic is associated with an improved bonding 
(Peretti et al., 1998; Peretti et al., 1999). Additionally, 
these features were not found in the control samples, 
confirming the need of cells to grant bonding between 
tissues. However, further in vivo studies in an orthotopic 
model are needed to evaluate the feasibility of this approach 
in a weight-bearing environment.
Partial meniscus engineering
From a clinical standpoint, partial meniscus regeneration 
represents a critical topic since the treatment of irreparable 
lesions of the avascular zone of the meniscus is still an 
open issue.
 Following the large clinical experience with CMI, 
Martinek et al. (2006) reported an interesting study on an 
autologous fibrochondrocytes-loaded CMI implanted in 
an ovine orthotopic model with a short-term follow up (3 
months). The implant was pre-cultured in vitro for 3 weeks 
to allow for cell adhesion and ECM deposition, and then 
implanted orthotopically. Cell-seeding was demonstrated 
to improve the mechanical properties and histological 
results. However, the tissue-engineered meniscus was 
biomechanically unstable and the implant size reduced 
during the three-month observation period. Therefore, the 
authors suggested that an improvement in scaffold and cell 
seeding procedure was required before human application.
 SIS has been applied to menisci regeneration in an 
orthotopic dog model in a 12 months follow-up study 
(Cook et al., 2006). In this study, partially meniscectomised 
menisci receiving cell-free SIS in a posterior vascular 
lesion had more tissue filling in the defects, with a 
meniscus-like tissue, and significantly less cartilage 
damage than menisci receiving no implants. Authors 
concluded that SIS implantation had better results than 
meniscectomy. Despite these positive experimental 
findings, it has been demonstrated that SIS evokes a TH-2 
lymphocytes mediated immune response (Ansaloni et al., 
2007), probably dependent on the presence of porcine 
DNA. However, this response usually does not determine 
graft rejection and it is used in clinical practice in inguinal 
hernioplasty (Ansaloni et al., 2007).
 MSC seeded onto a hyaluronan-collagen-based scaffold 
were recently used to repair a critical-size defect in an 
orthotopic rabbit model, with a tissue engineering approach 
(Angele et al., 2008). In this study, the authors removed 
the pars intermedia of the medial meniscus and replaced 
the resected section with the biocompatible scaffold only, 
or with the scaffold loaded with MSC and previously 
cultured in vitro for 14 d. Menisci repaired with the cell-free 
scaffold showed only a fibrous, scar-like repair tissue, while 
those repaired with the engineered tissue demonstrated 
a significantly better filling and meniscal regeneration. 
However, the cell-loaded and precultured implants did not 
completely restore the surface area and the tissue quality 
of normal meniscus. The authors concluded that, even if 
further studies are needed to optimise this approach, MSC 
demonstrated a potential for the regeneration of meniscal 
defects (Angele et al., 2008). In a more recent orthotopic 
study, the same authors evaluated the regeneration potential 
of hyaluronan-collagen matrices without cells, loaded 
with platelet-rich plasma, autologous bone marrow, or 
autologous MSC in a 2 mm punch defect model (Zellner 
et al., 2010). This study presented several interesting 
findings. First, neither bone marrow nor platelet-rich 
plasma loaded onto the matrices determined an improved 
healing compared with cell-free implants. Second, the 
implantation of 14 d precultured MSC-matrix constructs in 
chondrogenic medium resulted only in fibrocartilage-like 
repair tissue, displaying incomplete integration with the 
host meniscus. Third, non-precultured MSC in hyaluronan-
collagen composite matrices stimulated the development 
of completely integrated meniscus-like repair tissue. The 
latter suggests the potential for an intra-operative, one-
step approach for partial meniscus tissue engineering with 
autologous MSC and a proper biomaterial. However, the 
defect model used in this study does not reflect the typical 
meniscal lesion, and therefore the translation of this 
approach to clinical practice may require further studies.
Total meniscus engineering
Total meniscus tissue engineering may be considered as a 
potential alternative to allografts, in order to overcome by 
means of an autologous tissue the problems of availability, 
immune reaction and sizing related to allotransplantation. 
However, tissue engineering techniques have been applied 
to meniscal regeneration with controversial results, and 
only a few studies investigated in orthotopic models the 
feasibility of engineering total meniscus substitutes (Kon 
et al., 2008; Kang et al., 2006).
 Kang et al. (2006) described a PGA-PLGA scaffold 
seeded with allogeneic meniscal cells in a rabbit total 
meniscectomy model. The authors reported positive results 
at 36 weeks, with a neotissue resembling the normal 
meniscus by histology. Both the overall histological 
appearance and mechanical properties improved over 
the experimental times. Importantly, the seeded scaffolds 
showed no shrinkage or shape alterations at 36 weeks, 
while the unseeded scaffold showed failure of maintenance 
of shape and size. Less severe cartilage degeneration was 
observed in the rabbits treated with the seeded scaffolds. No 
or minor immune response was observed. In conclusion, 
this study demonstrated the feasibility of total meniscus 
substitution with a tissue engineering approach using 
a polymer scaffold and allogeneic fibrochondrocytes, 
highlighting the role of seeded cells in maintaining shape 
and size and for chondroprotection.
 A crucial aspect of scaffold design for meniscus 
tissue engineering was highlighted by Baker and Mauck 
(2007) reporting that nanofibres alignment served as a 
micro-pattern for directed tissue ingrowth and that, when 
cell-seeded with bovine meniscal cells or MSC, resulted 
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in better tissue properties in a PCL meniscal scaffold. An 
important finding of this study was that the improvement 
in mechanical properties depended on the overall better 
organisation of the tissue and not on a higher neotissue 
deposition. Considering the fine organisation of the native 
meniscal collagen fibres, these results seem particularly 
relevant to meniscal scaffold design. In a more recent 
study by the same authors with human cells harvested 
by adult human donors, they reported better results 
with fibrochondrocytes compared to MSC (Baker et al., 
2010). This concept has been further optimised, reaching 
near-native properties in tension, and showed multi-
scale collagen organisation in the scaffolds (Baker et al., 
2012). A further fibre-reinforced degradable scaffold for 
meniscus tissue engineering was developed by Balint et al. 
(2012) with the hypothesis that the fibre network design 
shares part of the compressive loads via the generation of 
circumferential tensile loads, resulting in tensile properties 
similar to those of the meniscus.
 Chiari et al. (2006) described the early results of a 
cell-free hyaluronan-PCL scaffold in an orthotopic large 
animal model. Their study was aimed to evaluate the 
biocompatibility, tissue ingrowth and neovascularisation 
properties of this material and demonstrated tissue 
formation and bonding to the capsule with an overall 
satisfactory integration in the host joint. Additionally, 
abundant blood vessels were found in the scaffold after 6 
weeks. According to these favourable preliminary results, 
Kon et al. (2008) investigated the use of this biomaterial 
seeded with expanded autologous articular chondrocytes 
in the same orthotopic model in order to improve the 
biological response and the remodelling processes. At the 
end of the experimental time (16 weeks) no significant 
macroscopic difference was evident between the cell-
seeded and the cell-free implant. However, histological 
analysis demonstrated deposition of cartilaginous matrix 
only in the cell-seeded scaffold. Moreover, the authors 
reported that the cartilaginous distribution was mainly 
located at the edges and the tip of the implants, consistent 
with the distribution of cells at the time of grafting, thus 
confirming that matrix deposition depended on or at least 
was enhanced by the previously seeded cells. Additionally, 
the implants were well tolerated immunologically, with 
only a mild foreign body giant-cell reaction. Limited 
peripheral implant extrusion was frequently observed. 
The authors concluded that the hyaluronan-PCL scaffold 
had a potential for total meniscus regeneration and that 
the seeding of the scaffold provided some benefits at 
4 months follow-up allowing for a larger amount of 
fibrocartilaginous tissue formation. A following study with 
12-month evaluation confirmed the improvement in tissue 
formation within the tissue engineered menisci, but showed 
no significant differences in protection from osteoarthritic 
degeneration between cell-seeded and cell-free scaffolds 
(Kon et al., 2012). However, both cell-seeded and cell-free 
implants resulted in better chondroprotection compared to 
meniscectomised knees.
 The results of an orthotopic study in dogs with 
a 6-month and 2-year follow up have been reported 
(Welsing et al., 2008; Hannink et al., 2011). In this study, 
they compared the outcome of total meniscectomy with 
that of the implant of a PU-PCL total meniscal implant. 
This work followed a large series of in vitro and in vivo 
experimental studies on the development of this scaffold 
(Heijkants et al., 2005; Heijkants et al., 2004; van Tienen 
et al., 2009). The authors described satisfactory integration 
and fibrovascular tissue ingrowth into the implant with 
mild foreign body reaction. However, specific structural 
organisation and a fibrocartilage phenotype was lacking 
after both 6 and 24 months. The porous polymer scaffold 
was histologically not noticeably degraded after 24 months, 
thus confirming the expected slow degradation rate of this 
implant. Surprisingly, chondroprotection was not superior 
compared to that of knees that underwent meniscectomy 
only. The authors concluded that further improvements 
in the implant model and surgical technique were needed 
for making the implant suitable for clinical application 
in totally meniscectomised patients. In fact, the clinical 
scenario in which a PU-PCL cell-free scaffold is currently 
used (Actifit™, Orteq Ltd, London, UK) is represented by 
irreparable meniscal tears or partial meniscal defects. In 
addition, in vitro studies are currently being performed to 
evaluate the feasibility of a cell-based approach using this 
scaffold (de Mulder et al., 2013). In particular, addition 
of TGF-β seems to be mandatory in order to promote MC 
proliferation and distribution throughout the construct (de 
Mulder et al., 2013).
 Kobayashi and co-workers described a cell-free total 
meniscus replacement model based on high water content 
PVA hydrogel in a rabbit model (Kobayashi et al., 2003; 
Kobayashi et al., 2005). Authors reported successful results 
in terms of chondroprotection. In particular, they proposed 
this strategy as salvage procedure for young athletes since 
it could allow for early return to athletic activity. However, 
some concerns have been raised regarding implant long-
term durability, safety and also on the fixation method. 
Another interesting cell-free hydrogel approach has been 
reported by Kelly et al. (2007), consisting of the use of a 
hydrogel-based implant that was secured and reinforced 
by sutures running circumferentially through it. However, 
significant cartilage degeneration and implant failure were 
seen at 1 year, and overall performance was worse than with 
allograft transplantation. The authors hypothesised that the 
source of graft failure arose from the size mismatch, the 
inadequate peripheral fixation of the hydrogel implant, or 
the structural composition of these particular implants.
 Mandal et al. (2011a) described the development 
of a tissue engineered meniscus based on a tri-layered 
silk fibrous protein scaffold and human expanded 
fibroblasts, seeded in the outer part, and human expanded 
chondrocytes, seeded in the inner part. According to the 
authors, its versatile processability, outstanding mechanical 
properties and biocompatibility make silk fibrous 
protein an ideal biopolymer for meniscus regeneration 
purposes. The rationale of using a tri-layered scaffold 
was to duplicate the native meniscus pores architecture. 
Fibroblasts and chondrocytes were seeded in each scaffold 
layer separately and cultured for 28 d. The resulting tissues 
displayed biochemical and biomechanical properties 
consistent with those of the native human meniscus. In a 
second study, the same authors reported the use of human 
MSC in such tri-layered scaffold showing native-like 
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compressive properties and tissue structure (Mandal et 
al., 2011b). However, the three layers should be combined 
firmly before an in vivo application is planned: the authors 
hypothesised that cell-deposited ECM and cell migration, 
eventually supplemented with stitches or a rivet approach 
(e.g., using silk cylindrical pieces pushed into holes through 
the layers) can help to keep together the three layers.
 An interesting and clinically-relevant approach 
is represented by image-guided tissue engineering of 
critically-sized whole meniscus constructs. In particular, 
because of its complex geometry, meniscus engineering 
can benefit from computer-aided design and tissue injection 
moulding techniques. Ballyns et al. (2008) demonstrated 
the feasibility of this approach by engineering a critically 
sized meniscus with bovine and ovine fibrochondrocytes 
suspended in agarose hydrogel. Even if the cells were not 
of human origin, this is an important proof of principle, 
opening new possibilities in meniscus tissue engineering.
 A further innovative strategy is represented by the 
development of a self-assembled, scaffold-free engineered 
meniscal tissue (Aufderheide and Athanasiou, 2007). 
According to this strategy, high-density co-cultures of MSC 
and fibrochondrocytes have been performed in ring-shaped 
moulds. This approach maximises cell-to-cell contact 
and interaction between differentiated fibrochondrocytes 
and undifferentiated MSC. An interesting finding of this 
study was that the tensile modulus was proportional to 
the percentage of fibrochondrocytes employed. However, 
a 50 % ratio of cells displayed overall better results. 
Scaffold-free constructs were also compared to cell-loaded 
PGA scaffold and were stiffer and stronger in tension with 
circumferential fibres similar to those of native tissue. 
On the other hand, cell-loaded PGA scaffold did not 
present a defined fibre direction. The authors suggested 
that the geometric constraint imposed by the ring-shaped, 
non-adhesive mould guided collagen fibril directionality 
and, thus, influenced mechanical properties. In another 
work, authors showed that the mechanical properties of a 
scaffoldless, self-assembled meniscus tissue, obtained by 
culturing bovine articular chondrocytes and meniscal cells 
in elliptical agarose wells, can be improved by addition of 
TGF-β1 and chondroitinase-ABC (Huey and Athanasiou, 
2011). In particular, in this study 20 million cells were 
used to engineer a rabbit-sized meniscus tissue. Although 
this method is very promising, the large number of cells 
needed represents a limitation to the clinical application of 
this approach, which, anyway, does not exclude the use of 
a biomaterial as augmentation to reach a clinically-relevant 
size with a reasonable number of cells (Makris et al., 2011).
 Although promising, results of recent experimental 
studies prompt for new strategies for total meniscus 
engineering as mere cell seeding does not result typically 
in an improved outcome and chondroprotection (Kon et al., 
2012). In addition, the ideal biomaterial for meniscus tissue 
engineering has still to be developed. For these reasons, 
alternative and more effective methods are desirable. 
In this regard, a critical tool to develop more functional 
engineered tissues, possibly leading to improved outcomes, 
is represented by bioreactors.
Bioreactors for meniscus engineering
Engineering of critically sized cellular grafts using 
standard static culture conditions is typically challenged 
by inefficient mass transport to the internal regions of the 
construct, ultimately resulting in cell death and necrosis in 
the tissue core (Martin et al., 2004). A possible solution to 
this issue is offered by bioreactor-based dynamic culture 
techniques, allowing for medium perfusion through the 
pores of the scaffold or convective media flow around the 
construct, thus overcoming diffusional transport limitations 
(Wendt et al., 2009). In the context of meniscus engineering, 
it was reported that hydrodynamic forces generated by a 
spinning impeller could result in the formation of bizonal 
tissues, resembling the structure and function of native 
meniscus (Marsano et al., 2006). In this study, medium 
mixing around the constructs imparted orientation of the 
extracellular matrix molecules in an outer zone and at the 
same time an enhanced mass transport in the inner zone. 
This resulted in the formation of circumferential collagen 
fibres in the peripheral region, associated with higher 
stiffness in tension, and in increased amounts of GAGs 
in the central region, associated with higher stiffness in 
compression. The range of effective mixing intensities, 
generated by different impeller speeds and quantified by the 
corresponding Reynolds numbers, was further investigated 
using anatomically shaped engineered constructs (Ballyns 
et al., 2010). The findings indicated that fluid mixing can 
be optimised to modulate the spatial heterogeneity of 
engineered menisci, as well as the correlated mechanical 
properties.
 Compressive deformation or hydrostatic pressure 
have alternatively been used to enhance the structure 
and function of engineered meniscus tissues. Dynamic 
compression of constructs based on micro-channelled 
scaffolds resulted in aligned cell layers and collagen 
fibres (Martinez et al., 2012), while hydrostatic pressure 
combined with TGF-β1 increased collagen and GAG 
deposition by meniscus cells, ultimately leading to 
enhanced compressive properties (Gunja and Athanasiou, 
2010). Cyclic tension specifically stimulated collagen I 
mRNA expression and protein synthesis, but had no effect 
on collagen II, aggrecan, or osteocalcin mRNA levels 
resulting in enhanced fibrochondrocyte-like differentiation 
of bone marrow-derived MSC (Connelly et al., 2010). 
Combinatorial modes of mechanical stimulation, including 
tension-compression loading (Huey and Athanasiou, 2011) 
or perfusion and cyclic compression (Petri et al., 2012), 
were also reported to additively increase matrix production 
and tissue mechanical properties.
 The availability of dynamic culture systems allowing 
generation of tissue grafts with superior mechanical 
properties raises the question of “how good is good 
enough?”, and thus what is the target level of functionality 
which is required to support a superior clinical outcome. 
Indeed, an increased level of maturation of engineered 
meniscus grafts would require not only more complex 
culture modalities, but also likely longer culture durations, 
which in view of a clinical translation would be reflected in 
higher manufacturing costs. Addressing this critical issue 
requires one to identify a match between the properties of 
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a meniscus graft and a suitable regime of post-operative 
rehabilitation. In this regard, the use of bioreactors 
applying regimes of forces mimicking those at the site of 
implantation offers the opportunity to investigate which 
structural and functional properties are sufficient to tolerate 
certain loading regimes that would be experienced by 
the graft upon implantation, or vice versa which loading 
regimes are compatible for grafts of a defined functionality 
(Dèmarteau et al., 2003).
 The introduction of bioreactor systems in the 
manufacturing of cellular grafts can not only be exploited 
to reach higher levels of tissue organisation and mechanical 
functionality, but also to reduce operator handling, 
automate processes and ultimately standardise the quality 
of the product (Martin et al., 2009). A bioreactor-based 
manufacturing would thus be critical to make tissue 
engineered products available at an industrial scale and 
quality, similar to what has been achieved in other better 
established biotechnological sectors (e.g., for production 
of antibodies, vaccines, and recombinant proteins).
 Finally, the use of state-of-the-art monitoring and 
control systems for relevant culture parameters, which is a 
standard feature of classical ‘fermenters’, would introduce 
the important advantage of a well-defined environment in 
the engineering of meniscus tissues. The availability of 
controlled culture conditions is crucial to test the effect 
of specific factors on the development of a meniscus 
tissue and would thus support a better understanding of 
regenerative processes at a cellular and molecular level 
(Rouwkema et al., 2011). Ultimately, this knowledge 
will be critical to identify factors that may induce in vivo 
regeneration and thus instrumental to operate the expected 
transition from the classical tissue-engineering approaches 
to the more modern concepts of regenerative medicine, 
relying on our body as the “in vivo bioreactor” for in situ 
tissue production.
Conclusion
Meniscus tissue is a crucial player in knee homeostasis. 
Re-establishing its integrity after injury is now considered 
a mandatory approach in knee surgery. However, current 
procedures result in variable outcomes while experimental 
strategies hold great potential to address this relevant 
clinical challenge. Cell-based biological bonding studies 
showed the possibility to improve the healing of meniscus 
tears treated with sutures, which would normally heal 
only in the red-red zone. However, the lack of efficient 
intra-operative systems for the isolation of autologous 
cells impedes its clinical application. Tissue engineering 
strategies showed several biological implants trying to 
address the regeneration of a part or the whole meniscus 
tissue when meniscectomy has to be performed. None of 
these cell-based strategies has entered clinical practice 
to date, since results on large animal studies have been 
controversial with no clear benefits. Functional engineered 
tissue has not been demonstrated to date upon orthotopic 
implantation. In fact, the relevance of engineered tissue 
generated ectopically (e.g., in subcutaneous pouches of 
nude mice) is limited and more pre-clinical evidence in 
large animals orthotopic models is desirable. In addition, the 
ideal biomaterial characterised by appropriate mechanical 
properties and providing adequate environment to cells 
for tissue regeneration has still to be described. However, 
new technologies and advancements in molecular biology, 
genetics and bioengineering research have the potential 
to foster meniscus research towards the solution of this 
clinical challenge.
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